These results suggest that CTBP1 might be a valuable target involved in the progression of NSCLC due to its role as a transcriptional suppressor, and that JAC4 targeted CTBP1 and therefore rescued the expression of tumor suppressors like JWA. The gene discussed is ARL6IP5; the disease is non-small cell lung carcinoma.